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Introduction {#jdi12043-sec-0005}
============

Diabetes mellitus is a common disease worldwide. Its prevalence is increasing, and varies greatly across geographical areas[1](#jdi12043-bib-0001 jdi12043-bib-0002 jdi12043-bib-0003 jdi12043-bib-0004){ref-type="ref"}.

In Italy, the overall prevalence has been estimated to be approximately 5%[5](#jdi12043-bib-0005){ref-type="ref"}, but the country is geographically and culturally heterogeneous, and disparities exist in health‐related factors[6](#jdi12043-bib-0006){ref-type="ref"}. Friuli Venezia Giulia (FVG) is a 1,200,000‐inhabitant region located in northeastern Italy. In FVG, a regional health information system allows for comprehensive assessments of the health status of the population though the analysis of administrative health‐related databases.

The objective of the present study was to estimate the prevalence of known diabetes mellitus in the FVG region based on the health information system, and to assess the relationships among the diseases that accompany diabetes mellitus using association rule mining (ARM) on the regional large administrative databases.

Methods {#jdi12043-sec-0006}
=======

Prevalence of Known Diabetes {#jdi12043-sec-0007}
----------------------------

The sources of information for estimating prevalence were the administrative health databases of the FVG region, included in a regional repository of data for epidemiological studies: (i) hospital discharges; (ii) exemptions from medical charges (in Italy, diabetics can obtain medicines, visits and devices free of charge from the National Health System, after being certified); (iii) pharmaceutical prescriptions; and (iv) outpatient visits. In each database, patients are identified through an anonymous univocal identification number that allows individual linkage of records from different databases. Classification of type 1 and type 2 diabetes mellitus is not possible according to those sources, therefore, both types of diabetes are included in our estimates. However, according to the World Health Organization, type 2 diabetes comprises 90% of people with diabetes worldwide[7](#jdi12043-bib-0007){ref-type="ref"}.

The prevalence among residents in the region was estimated as of 31 December 2010, the most recent date when all databases were complete. The prevalence was calculated according to two different definitions:

Any hospital discharge from 2000 to 2010 with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) = 250.xx in any diagnosis position; or being exempt from medical charges because of diabetes mellitus (regional codes 'P20',\'013\'); or being prescribed ≥3 packages of medications with Anatomical Therapeutic Chemical (ATC)[8](#jdi12043-bib-0008){ref-type="ref"} codes A10Axx or A10Bxx within 365 days;Criteria in definition 1; OR ≥2 outpatient blood withdrawal for glycated hemoglobin (HbA~1c~) measurement (regional code 90.28.1) within 365 days; or ≥1 medications with ATC codes A10Axx or A10Bxx and ≥1 outpatient blood withdrawal for HbA~1c~ measurement (regional code 90.28.1) within 365 days.

The use of different criteria based on different sources of information should minimize the possibility of underestimating the prevalence. A more accurate estimation will be possible when the actual HbA~1c~ concentration measured in blood is available for epidemiological analyses.

The prevalence of known diabetes was also estimated stratified by sex and age category (\<60; 60--69, 70--79, ≥80 years). To allow for international comparison, we also calculated the directly standardized prevalence of known diabetes mellitus using the Segi world population as the standard[9](#jdi12043-bib-0009){ref-type="ref"}.

Comorbidities of Diabetes {#jdi12043-sec-0008}
-------------------------

To assess the relationships among the diseases that occur in association with diabetes mellitus, we used ARM. Association rules are of the form if A then B (A⇒B). ARM is widely used by marketing professionals to recognize affinities among products, but it can also be applied to medical histories of patients to detect particular combinations of conditions or diagnoses (Dx)[10](#jdi12043-bib-0010 jdi12043-bib-0011 jdi12043-bib-0012){ref-type="ref"}.

The algorithm rules specify when a certain item set A (DxA) appears in a database and another item set (DxB) appears in association with it. The rules are evaluated by support, confidence and lift. Support is the percentage of occurrences of DxA and DxB out of all diseases. It can be seen as the probability of the co‐occurrence of DxA and DxB, and is direction independent. Confidence is the ratio of the support of the co‐occurrence of DxA and DxB to the occurrences of DxA, and can be seen as a direction‐dependent conditional probability. To take a rule into consideration, we impose a minimum support (s0); that is, a reasonably large amount of data about the rule, and a minimum confidence (c0); that is, a reasonably good predictivity of the rule. A strong rule is one with support \>s0 and confidence \>c0. Interesting rules, however, should also show a reasonable lift or improvement, which is the ratio of the support of the co‐occurrence of DxA and DxB to the product of the support of DxA, and the support of DxB. A lift \>1 indicates that that the association between DxA and DxB is due to more than just chance alone.

The analysis of comorbidities was based on hospital discharges in 2011, the most recent available year. All the patients who were admitted to any of the FVG hospitals and discharged in the year 2011 were included in the analysis.

Five‐digit ICD‐9‐CM codes were recoded into three‐digit codes, because more specific codes would have given low support item sets. Duplicate records (i.e. those with the same diagnosis for the same patient) were removed from the analysis. The association rules were determined by the RapidMiner 5.2.008 free software (Rapid‐I GmbH, Dortmund, Germany). The threshold for values was established as s0 \>0.5% for support and c0 \>5% for confidence. The statistical significance of the rules identified by ARM was tested through chi‐square tests.

Results {#jdi12043-sec-0009}
=======

The regional prevalence of known diabetes mellitus as of 31 December 2010 was 6.0% according to definition 1 and 8.1% according to definition 2. Using the Segi world population, the directly standardized prevalence of known diabetes according to definition 2 was 3.7%. There was great variability of age‐ and sex‐specific prevalences, as shown in Table [1](#jdi12043-tbl-0001){ref-type="table-wrap"}, with diabetes being relatively rare in people aged younger than 60 years. In all sex and age groups, the prevalence estimated according to definition 2 was 30--40% higher than according to definition 1.

###### Sex and age‐specific prevalence of diabetes in Friuli Venezia Giulia, northeastern Italy, 31 December 2010

  Sex and age (years)   Diabetes definition 1[a](#jdi12043-note-0001){ref-type="fn"}   Diabetes definition 2[b](#jdi12043-note-0002){ref-type="fn"}             
  --------------------- -------------------------------------------------------------- -------------------------------------------------------------- --------- ------
  Females                                                                                                                                                       
  0--59                 7,976                                                          1.9                                                            11,551    2.7
  60--69                7,556                                                          9.1                                                            10,558    12.7
  70--79                9,792                                                          13.8                                                           13,668    19.3
  ≥80                   9,288                                                          15.5                                                           12,283    20.4
  Males                                                                                                                                                         
  0--59                 9,774                                                          2.2                                                            13,121    3.0
  60--69                12,294                                                         15.8                                                           16,280    21.0
  70--79                11,827                                                         21.0                                                           16,120    28.6
  ≥80                   5,294                                                          19.2                                                           6,985     25.4
  Total                 73,801                                                         6.0                                                            100,566   8.1

Diabetes definition 1: any hospital discharge from 2000 to 2010 with International Classification of Diseases, ninth revision, Clinical Modification = 250.xx in any diagnosis position; or being exempt from medical charges because of diabetes mellitus (regional codes 'P20',\'013\'); or being prescribed ≥3 medications with Anatomical Therapeutic Chemical (ATC) codes A10Axx or A10Bxx within 365 days.

Diabetes definition 2: criteria in definition 1; or ≥2 outpatient blood withdrawal for glycated hemoglobin (HbA~1c~) measurement (regional code 90.28.1) within 365 days; or ≥1 medications with ATC codes A10Axx or A10Bxx and ≥1 outpatient blood withdrawal for HbA~1c~ measurement (regional code 90.28.1) within 365 days.
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In 2011, 155,494 patients were admitted to the regional hospitals at least once, totalling 416,396 diagnostic records with non‐duplicate three‐digit ICD‐9‐CM codes. The number of patients with a diagnosis of diabetes was 9,358, with 46,897 diagnostic records with non‐duplicate three‐digit ICD‐9‐CM codes and 659 distinct three‐digit ICD‐9‐CM codes other than 250 (diabetes mellitus).

The diagnoses that were most frequently associated with diabetes mellitus are shown in Table [2](#jdi12043-tbl-0002){ref-type="table-wrap"}. We obtained 12 rules between diabetes mellitus and comorbid diagnoses (Table [3](#jdi12043-tbl-0003){ref-type="table-wrap"}). The rule with the highest support and confidence was diabetes mellitus⇒essential hypertension. Three rules identified two comorbid diagnoses simultaneously associated with diabetes mellitus.

###### Comorbid discharge diagnoses frequently associated with diabetes (International Classification of Diseases, Ninth Revision, Clinical Modification code 250) among patients discharged from hospital in Friuli Venezia Giulia, northeastern Italy, in 2011

  ------------------------------------------------------------------------------------------
  ICD‐9‐CM   Diagnosis name                                  *n*     Diabetic patients (%)
  ---------- ----------------------------------------------- ------- -----------------------
  401        Essential hypertension                          3,692   39.5

  427        Cardiac dysrhythmias                            2,058   22.0

  414        Other forms of chronic ischemic heart disease   2,031   21.7

  428        Heart failure                                   1,848   19.8

  402        Hypertensive heart disease                      1,530   16.4

  585        Chronic kidney disease                          1,272   13.6

  491        Chronic bronchitis                              1,082   11.6

  272        Disorders of lipoid metabolism                  953     10.2

  518        Other diseases of lung                          860     9.2

  278        Overweight, obesity and other\                  733     7.8
             \                                                       
             hyperalimentation                                       

  440        Atherosclerosis                                 715     7.6

  437        Other ill‐defined cerebrovascular disease       643     6.9

  571        Chronic liver disease and cirrhosis             592     6.3
  ------------------------------------------------------------------------------------------

*n *= 9,358. ICD‐9‐CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
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###### Association rules between diabetes (International Classification of Diseases, Ninth Revision, Clinical Modification code 250) and comorbid discharge diagnoses, support, confidence and lift in Friuli Venezia Giulia, northeastern Italy, in 2011

  ----------------------------------------------------------------------------------------------------
  Rule                                                           *n*    Support   Confidence   Lift
  -------------------------------------------------------------- ------ --------- ------------ -------
  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            3692   2.4       39.5         3.968
  \                                                                                            
  ICD‐9‐CM 401 (essential hypertension)                                                        

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            2058   1.3       22.0         2.975
  \                                                                                            
  ICD‐9‐CM 427 (cardiac dysrhythmias)                                                          

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            2031   1.3       21.7         4.360
  \                                                                                            
  ICD‐9‐CM 414 (other forms of chronic ischemic heart disease)                                 

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            1848   1.2       19.7         3.918
  \                                                                                            
  ICD‐9‐CM 428 (heart failure)                                                                 

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            1530   1.0       16.3         4.118
  \                                                                                            
  ICD‐9‐CM 402 (hypertensive heart disease)                                                    

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            1272   0.8       13.6         4.888
  \                                                                                            
  ICD‐9‐CM 585 (chronic kidney disease)                                                        

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            1082   0.7       11.6         3.548
  \                                                                                            
  ICD‐9‐CM 491 (chronic bronchitis)                                                            

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            953    0.6       10.2         3.782
  \                                                                                            
  ICD‐9‐CM 272 (disorders of lipoid metabolism)                                                

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            860    0.6       9.2          2.878
  \                                                                                            
  ICD‐9‐CM 518 (other diseases of the lung)                                                    

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            859    0.6       9.2          3.964
  \                                                                                            
  ICD‐9‐CM 427 (cardiac dysrhythmias),\                                                        
  \                                                                                            
  ICD‐9‐CM 428 (heart failure)                                                                 

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            852    0.5       9.1          5.443
  \                                                                                            
  ICD‐9‐CM 401 (essential hypertension),\                                                      
  \                                                                                            
  ICD‐9‐CM 414 (other forms of chronic ischemic heart disease)                                 

  ICD‐9‐CM 250 (diabetes mellitus) ⇒\                            829    0.5       8.9          4.017
  \                                                                                            
  ICD‐9‐CM 401 (essential hypertension),\                                                      
  \                                                                                            
  ICD‐9‐CM 427 (cardiac dysrhythmias)                                                          
  ----------------------------------------------------------------------------------------------------

*n* = 155,494. ICD‐9‐CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
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Persons discharged from the hospital with a diagnosis of diabetes mellitus are significantly more likely than the others to have the comorbid discharge diagnosis sets identified through the ARM process (Table [4](#jdi12043-tbl-0004){ref-type="table-wrap"}).

###### Statistical significance of the associations rules between diabetes (International Classification of Diseases, Ninth Revision, Clinical Modification code 250) and comorbid discharge diagnoses in Friuli Venezia Giulia, northeastern Italy, in 2011

  ICD‐9‐CM   Diagnosis name                                                          Subjects with ICD‐9‐CM 250 discharge diagnosis   Subjects with no ICD‐9‐CM 250 discharge diagnosis   χ^2^ *P*‐value         
  ---------- ----------------------------------------------------------------------- ------------------------------------------------ --------------------------------------------------- ---------------- ----- ----------
  401        Essential hypertension                                                  3,692                                            39.5                                                11,769           8.1   \<0.0001
  427        Cardiac dysrhythmias                                                    2,058                                            22.0                                                9,437            6.5   \<0.0001
  414        Other forms of chronic ischemic heart disease                           2,031                                            21.7                                                5,709            3.9   \<0.0001
  428        Heart failure                                                           1,848                                            19.8                                                5,990            4.1   \<0.0001
  402        Hypertensive heart disease                                              1,530                                            16.4                                                4,644            3.2   \<0.0001
  585        Chronic kidney disease                                                  1,272                                            13.6                                                3,052            2.1   \<0.0001
  491        Chronic bronchitis                                                      1,082                                            11.6                                                3,985            2.7   \<0.0001
  272        Disorders of lipoid metabolism                                          953                                              10.2                                                3,234            2.2   \<0.0001
  518        Other diseases of lung                                                  860                                              9.2                                                 4,106            2.8   \<0.0001
  427,428    Cardiac dysrhythmias, heart failure                                     859                                              9.2                                                 2,742            1.9   \<0.0001
  401,414    Essential hypertension, other forms of chronic ischemic heart disease   852                                              9.1                                                 1,749            1.2   \<0.0001
  401,427    Essential hypertension, cardiac dysrhythmias                            829                                              8.9                                                 2,600            1.8   \<0.0001

*n* = 155,494. ICD‐9‐CM, International Classification of Diseases, Ninth Revision, Clinical Modification.

John Wiley & Sons, Ltd

Discussion {#jdi12043-sec-0010}
==========

In this region of northeastern Italy, 73,000--100,000 of the 1,200,000 inhabitants are estimated to have known diabetes mellitus. Our prevalence estimates (6.0--8.1%) were much higher than those reported in the national official statistics: 4.9% according to the Italian National Institute of Statistics[5](#jdi12043-bib-0005){ref-type="ref"} in 2011, as reported by the citizens interviewed in the national survey Indagine Multiscopo 'Aspetti della vita quotidiana', and 5% as estimated by the national health surveillance system (Progressi delle Aziende Sanitarie per la Salute in Italia \[PASSI\])[13](#jdi12043-bib-0013){ref-type="ref"}. However, the study designs used for the national statistics are different from ours (surveys of population samples and self‐reports vs analysis of administrative health databases with full coverage of the population), and the resulting estimates are hardly comparable.

In contrast, methods similar to ours were used in a recent study carried out in the northern Italian region of Lombardy[14](#jdi12043-bib-0014){ref-type="ref"}. The sources of information were hospital discharge data (DRG), exemptions from medical charges and medicine prescriptions. The crude prevalence of type 1 and type 2 diabetes mellitus in that study was 4.2% -- much lower than ours. However, all age‐specific frequencies were higher than in FVG. This suggests that the crude prevalence of known diabetes mellitus in FVG is higher than in other Italian regions because of the age structure of the population. In fact, FVG has one of the highest ratios of residents aged ≥65 years over those aged 0--14 years in the country[15](#jdi12043-bib-0015){ref-type="ref"}.

The validity of identifying cases of diabetes from administrative data is still unknown in Italy. A review of international studies showed that administrative databases were adequately sensitive and highly specific[16](#jdi12043-bib-0016){ref-type="ref"}. In Canada, recent research showed that, relative to three standard definitions of diabetes based on laboratory data, the use of a combination of administrative hospital discharge data and physician claims data underestimated the prevalence of diagnosed diabetes by at least 20%[17](#jdi12043-bib-0017){ref-type="ref"}. In the present study, we used multiple data sources, which should minimize the possibility of underestimating the prevalence. The estimated prevalence increased by more than 30% when we included among the criteria for case identification having at least two measurements of HbA~1c~ in 365 days, consistently with current clinical recommendations[18](#jdi12043-bib-0018){ref-type="ref"}. An improvement in case ascertainment validity will be possible through the individual linkage with the HbA~1c~ values actually measured in our patients, currently not available for epidemiological analyses. Of course, the administrative databases that we used will never capture cases of diabetes that are clinically unrecognized.

Knowing that there are at least 73,000 diabetic patients in the FVG region, and that most of them are elderly, is important from the public health standpoint and for the regional health policy planning. Other information that is extremely important for organizing healthcare and management of diabetics regards comorbidities. For this reason, we studied through ARM the comorbidities that are often associated with diabetes mellitus.

Association rule mining proved efficient and effective in identifying new and interesting patterns in health data[19](#jdi12043-bib-0019 jdi12043-bib-0020){ref-type="ref"}, and in particular in comorbidity studies using large health databases[10](#jdi12043-bib-0010 jdi12043-bib-0011 jdi12043-bib-0012){ref-type="ref"}. This method has some limitations, such as the lack of uniform criteria for setting thresholds for support and lift[20](#jdi12043-bib-0020){ref-type="ref"}, and the generation of superfluous patterns[21](#jdi12043-bib-0021){ref-type="ref"}. Nonetheless, it was useful to confirm in an Italian context associations between diabetes mellitus and comorbid diagnoses, most of which had been shown in other settings[10](#jdi12043-bib-0010){ref-type="ref"}.

Diabetes mellitus is frequently associated with essential hypertension. Patients with both conditions are much more likely to have coronary heart disease, and to experience more severe cardiomyopathy and complications than those with either one[22](#jdi12043-bib-0022){ref-type="ref"}, and should be treated to control both blood pressure and glucose levels.

We noticed an association of diabetes mellitus with different heart diseases. In regard to dysrhythmias, diabetes mellitus has been shown to significantly alter the cardiac electrophysiology[23](#jdi12043-bib-0023){ref-type="ref"} and, in particular, the association of diabetes with increased risk of atrial fibrillation is well known[24](#jdi12043-bib-0024){ref-type="ref"}. Several mechanisms have been proposed, however, not one has been demonstrated[24](#jdi12043-bib-0024){ref-type="ref"}. Heart failure was reported to have worse outcomes among diabetic patients than among the others, and diabetes might influence the clinical choice of carrying out revascularization in case of ischemic heart failure[25](#jdi12043-bib-0025){ref-type="ref"}. Recognizing diabetic status is fundamental for the correct management and treatment of patients with heart failure[26](#jdi12043-bib-0026){ref-type="ref"}. Hypertensive heart disease was also common in our cohort. Diabetes mellitus affects the pattern of left ventricular hypertrophic response to hypertension[27](#jdi12043-bib-0027){ref-type="ref"}, and good glycemic control reduces left ventricular hypertrophy both in patients with type 2 diabetes and in those with type 1 diabetes[28](#jdi12043-bib-0028 jdi12043-bib-0029){ref-type="ref"}.

Chronic kidney disease is another condition that is often associated with diabetes. Diabetes is a frequent cause of kidney disease, and is the primary cause of kidney failure for many patients who receive dialysis. Patients with a combination of the two conditions are at a higher risk of cardiovascular events than the others and need to be carefully treated. However, the clinical management of those patients is difficult; kidney dysfunction might impose an adjustment of the medication therapy to control diabetes[30](#jdi12043-bib-0030){ref-type="ref"}.

Regarding the association with chronic bronchitis and other diseases of the lung, in the Women\'s Health Study, women with chronic obstructive pulmonary disease were shown to have an increased risk of developing type 2 diabetes mellitus, independent of smoking status and other known risk factors for diabetes[31](#jdi12043-bib-0031){ref-type="ref"}. A possible explanation for this association is the existence of a common inflammatory basis between the two conditions. Behaviors that reduce diabetes risk among patients with chronic lung disease should be encouraged.

In our diabetic population, disorders of lipoid metabolism were also common. Impaired insulin action modifies the adipocyte metabolism, ultimately leading to an alteration of plasma lipids, with increased very‐low‐density lipoproteins, decreased high‐density lipoprotein, and small and dense low‐density lipoprotin[32](#jdi12043-bib-0032){ref-type="ref"}, and increased risk of cardiovascular events. Correcting dyslipidemia in diabetic patients is, therefore, particularly important.

In addition to the aforementioned associations, ARM identified three rules in which two comorbid diagnoses were associated with diabetes mellitus. Although the mechanisms underlining such associations are not always fully explained and more research is required to clarify them, the present study shows that diabetics are undoubtedly complex patients and reminds us that their clinical management cannot neglect comorbidities. In this perspective, the association rules generated in the present study might be regarded as useful; they are not trivial, because the comorbidities of diabetes had never been studied before in this population; they are not inexplicable, because they have plausible explanations; they are actionable.

The results of our ARM, however, should not be generalized to the overall population of diabetics. In fact, patients who are admitted to the hospital are likely to be different from those who do not require hospitalization, who are the majority. They might differ in a number of aspects, such as disease seriousness, socioeconomic and marital status, and comorbidity pattern.

In conclusion, we estimated that 6--8% of the population of FVG has known diabetes mellitus, with great variations by age group. Among diabetics who are admitted to the hospital, comorbidities are frequent and should be taken into consideration in the clinical management of those patients.
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